首页524804 • BOM
add
Aurobindo Pharma Ltd
昨日收盘价
₹1,223.95
当日价格范围
₹1,221.00 - ₹1,243.00
年度波幅
₹959.05 - ₹1,592.55
市值
7295.28亿 INR
平均交易量
1.32万
市盈率
20.19
股息率
-
主要交易所
NSE
相关资讯
财务信息
损益表
收入
净收入
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 779.61亿 | 7.99% |
经营支出 | 340.19亿 | 13.51% |
净收入 | 81.74亿 | 7.95% |
净利润率 | 10.48 | -0.10% |
每股收益 | 14.00 | 9.12% |
息税折旧摊销前利润 | 157.71亿 | 16.15% |
有效税率 | 32.34% | — |
资产负债表
总资产
负债总额
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 686.82亿 | -3.93% |
总资产 | 4809.44亿 | 9.50% |
负债总额 | 1720.95亿 | 9.41% |
权益总额 | 3088.50亿 | — |
发行在外的股份 | 5.84亿 | — |
市净率 | 2.31 | — |
资产回报率 | — | — |
资本回报率 | 7.81% | — |
现金流
现金净变动
| (INR) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | 81.74亿 | 7.95% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
成立时间
1986
员工数量
26,015
